SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-003032
Filing Date
2008-03-18
Accepted
2008-03-18 17:16:35
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183530z10-k.htm 10-K 1229226
2 EXHIBIT 3.5 a2183530zex-3_5.htm EX-3.5 85264
3 EXHIBIT 21.0 a2183530zex-21_0.htm EX-21.0 2514
4 EXHIBIT 23.1 a2183530zex-23_1.htm EX-23.1 4633
5 EXHIBIT 31.1 a2183530zex-31_1.htm EX-31.1 7075
6 EXHIBIT 31.2 a2183530zex-31_2.htm EX-31.2 7092
7 EXHIBIT 32 a2183530zex-32.htm EX-32 3817
8 G169211.JPG g169211.jpg GRAPHIC 24196
  Complete submission text file 0001047469-08-003032.txt   1374588
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 08697153
SIC: 2835 In Vitro & In Vivo Diagnostic Substances